• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Brooks Laboratories Ltd

+ Add to Watchlist

BKL:IN

41.20 INR 0.45 1.08%

As of 07:05:47 ET on 09/19/2014.

Snapshot for Brooks Laboratories Ltd (BKL)

Open: 41.45 Day's Range: 39.25 - 42.70 Volume: 126,237
Previous Close: 41.65 52wk Range: 13.49 - 53.10 1-Yr Rtn: +189.12%

Stock Chart for BKL

No chart data available.
  • BKL:IN 41.20
  • 1D
  • 1M
  • 1Y
41.65
Interactive BKL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BKL

Current P/E Ratio (ttm) 7.5474
Estimated P/E(-) -
Relative P/E vs. SENSEX 0.4005
Earnings Per Share (ttm) 5.4588
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 666.88
Shares Outstanding (M) 16.19
30 Day Average Volume 289,730
Price/Book (mrq) 0.7307
Price/Sale (ttm) 0.7823
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BKL

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for BKL

Brooks Laboratories Limited is a research and development driven pharmaceutical manufacturing company. The Company is a contract manufacturing company for the latest molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.

Atul RanchalChairman/Executive DirectorRajesh MahajanManaging Director/Co-Founder
Durga Sankar MaityCEO/Exec Dir/Tech DirKetan ShahChief Financial Officer
More Company Profile & Key Executives for BKL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil